Skip to main content
. 2016 Oct 25;8(10):17258–17269. doi: 10.18632/oncotarget.12907

Table 1. Characteristics of studies included in meta-analysis of surgical margin status and bladder cancer outcomes.

Study Country/Type Period Mean follow -up(months) Mean age Sample-size Positive SM(%) Positive LN(%) T stage(%)
Soave 2015 [21] Germany; single-center study 1996-2011 45.0 67.0 517 12.0 26.7 ≤T2:55.5; ≥T3:44.5
Satkunasivam 2015 [10] USA; single-center study 1971-2009 148.8 66.2 2047 0.0 NA ≤T2:63.3; ≥T3:36.7
Reder 2015 [8] USA; single-center study 2000-2012 20.0 67.9 364 10.7 20.0 ≤T2:54.1; ≥T3:44.5
Raza 2015 [34] International multicenter study 2003-2015 67.0 69.0 702 8.0 21.0 ≤T2:62.0; ≥T3:38.0
Kanatani 2015 [29] Japan; single-center study 1990-2012 29.0 64.0 61 11.5 50.8 ≤T2:13.1; ≥T3:86.9
Gakis 2015 [35] International multicenter study 1994-2011 64.0 54.0 297 2.4 20.2 ≤T2:40.4; ≥T3:59.6
Booth 2015 [11] Canada; single-center study 1994-2008 NA 72.0 2802 13.0 29.0 ≤T2:29.0; ≥T3:71.0
Aziz 2015 [36] International multicenter study 1989-2011 40.0 68.0 856 24.8 53.6 ≤T2:0.0; ≥T3:100.0
Albisinni 2015 [22] International multicenter study 2000-2013 50.0 68.0 503 5.8 23.1 ≤T2:57.9; ≥T3:42.1
Yuh 2014 [12] USA; single-center study 2004-2012 52.0 70.0 162 4.3 21.6 ≤T2:66.7; ≥T3:33.3
Suer 2014 [30] Turkey; single-center study 1990-2012 37.7 66.5 290 7.6 14.5 ≤T2:54.8; ≥T3:45.2
Sejima 2014 [31] Japan; single-center study 2003-2011 24.8 71.1 249 4.4 15.7 ≤T2:56.6; ≥T3:43.4
Ploussard 2014 [37] International multicenter study 1979-2012 32.2 68.0 8141 23.7 23.7 ≤T2:56.8; ≥T3:43.2
Nieuwenhuijzen 2014 [23] Netherlands; single-center study 1990-2006 64.0 62.3 343 10.0 34.0 ≤T2:52.0; ≥T3:48.0
May 2014 [24] International multicenter study 1989-2008 36.0 67.0 385 22.3 51.4 ≤T2:0.0; ≥T3:100.0
Lin 2014 [12] USA; single-center study 1990-2010 66.0 68.0 196 0.0 NA ≤T2:100.0; ≥T3:0.0
Kluth 2014 [38] International multicenter study 1998-2010 36.1 67.0 2895 5.5 26.9 ≤T2:53.9; ≥T3:46.1
Klatte 2014 [39] International multicenter study 1979-2012 41.0 67.5 7906 5.3 23.8 ≤T2:58.1; ≥T3:41.9
Bruins 2014 [25] Netherlands; single-center study 1998-2011 75.6 65.0 245 2.9 NA ≤T2:64.9; ≥T3:35.1
Bachir 2014 [14] Canada; multicenter study 1998-2008 39.0 65.6 847 10.6 22.4 ≤T2:49.8; ≥T3:50.2
Lotan 2013 [9] USA; single-center study 2007-2012 20.0 70.0 216 7.0 25.0 ≤T2:60.0; ≥T3:40.0
Fritsche 2013 [26] Germany; multicenter study 2006-2010 20.0 69.0 158 26.6 100.0 ≤T2:19.6; ≥T3:80.4
Todenhofer 2012 [27] Germany; single-center study 1999-2010 30.0 67.8 258 10.1 27.1 ≤T2:50.4; ≥T3:49.6
Mitra 2012 [15] USA; single-center study 1971-2005 31.2 62.3 447 7.8 48.8 ≤T2:26.6; ≥T3:24.6
Gondo 2012 [32] Japan; single-center study 2000-2009 26.8 68.0 194 10.3 10.8 ≤T2:55.7; ≥T3:44.3
Yafi 2011 [16] Canada; multicenter study 1998-2008 35.0 68.0 2287 8.6 25.9 ≤T2:48.1; ≥T3:51.9
Sonpavde 2011 [40] International multicenter study 1971-2008 39.4 68.5 578 4.0 0.0 ≤T2:0.0; ≥T3:100.0
Hofner 2011 [28] Germany; single-center study 1990-2009 104.4 64.0 328 17.0 36.0 ≤T2:49.0; ≥T3:51.0
Tilki 2010 [41] International multicenter study 1979-2008 55.0 68.9 583 24.9 53.5 ≤T2:0.0; ≥T3:100.0
Kim 2010 [33] Korea; single-center study 1986-2005 66.3 60.8 406 3.9 12.1 ≤T2:67.2; ≥T3:32.8
Fairey 2009 [17] Canada; single-center study 1994-2007 31.0 66.0 523 12.0 23.0 ≤T2:49.0; ≥T3:51.0
Chapman 2009 [18] USA; single-center study 1996-2006 34.3 66.4 308 12.7 27.3 ≤T2:49.0; ≥T3:51.0
Canter 2009 [19] USA; single-center study 1988-2006 46.4 65.5 344 11.6 NA ≤T2:89.0; ≥T3:11.0
Dotan 2007 [4] USA; single-center study 1985-2005 NA 65.9 1589 4.2 24.0 ≤T2:54.0; ≥T3:46.0
Lee 2006 [7] Korea; single-center study 1995-2002 37.1 61.0 115 4.3 0.0 NA
Herr 2004 [20] USA; multicenter study 1987-1998 106.8 64.6 242 10.0 20.5 ≤T2:69.0; ≥T3:31.0

Abbreviations: SM, surgical margin; LN, lymph node; NA, data not applicable

HHS Vulnerability Disclosure